Filana Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2009 | $-14.7M | $-14.7M | — | $6.7M |
| FY2010 | $-143.0K | $-143.0K | — | $20.1M |
| FY2011 | $-260.0K | $-260.0K | — | $5.4M |
| FY2012 | $-7.2M | $-7.2M | — | $6.6M |
| FY2013 | $-6.9M | $-6.9M | — | $3.1M |
| FY2014 | $-9.5M | $-9.6M | $80.0K | $3.8M |
| FY2015 | $-9.1M | $-9.2M | $195.0K | $3.5M |
| FY2016 | $-12.2M | $-12.3M | $75.0K | $4.3M |
| FY2017 | $-8.2M | $-8.2M | — | $3.0M |
| FY2018 | $-4.8M | $-4.8M | — | $2.4M |
| FY2019 | $-2.5M | $-2.5M | $18.0K | $1.3M |
| FY2020 | $-5.4M | $-5.4M | — | $988.0K |
| FY2021 | $-30.2M | $-52.4M | $22.2M | $1.8M |
| FY2022 | $-77.5M | $-80.2M | $2.7M | $2.1M |
| FY2023 | $-82.0M | $-82.4M | $414.0K | $4.6M |
| FY2024 | $-116.9M | $-117.0M | $103.0K | $16.3M |
| FY2025 | $-32.3M | $-32.8M | $581.0K | $19.6M |